Page last updated: 2024-08-26

jjc 323 and azathioprine

jjc 323 has been researched along with azathioprine in 2 studies

*Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) [MeSH]

*Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crawford, DJ; Jones, DN; Maddocks, JL; Szawlowski, P1
Jamoulle, JC; Lapière, CL; Van Caneghem, P1

Other Studies

2 other study(ies) available for jjc 323 and azathioprine

ArticleYear
Rational design of novel immunosuppressive drugs: analogues of azathioprine lacking the 6-mercaptopurine substituent retain or have enhanced immunosuppressive effects.
    Journal of medicinal chemistry, 1996, Jul-05, Volume: 39, Issue:14

    Topics: Animals; Azathioprine; Cells, Cultured; Drug Design; Humans; Immunosuppressive Agents; Lymphocyte Culture Test, Mixed; Male; Mercaptopurine; Mice; Skin Transplantation; Structure-Activity Relationship

1996
[Radiosensitizing properties of an analog of azathioprine].
    Annales pharmaceutiques francaises, 1985, Volume: 43, Issue:4

    Topics: Animals; Azathioprine; Metronidazole; Mice; Mice, Inbred C57BL; Radiation-Sensitizing Agents; Structure-Activity Relationship; Triazoles

1985